SELENOMETHIONINE SE 75
LOE ApproachingNDAINJECTIONINJECTABLE
Approved
Nov 1976
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
1/8 — Limited
Drug data last refreshed 4h ago · AI intelligence enriched 1w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
SELENOMETHIONINE SE 75 is a radioactive diagnostic agent administered by injection, used in nuclear medicine imaging procedures. It is an amino acid-based radiopharmaceutical containing selenium-75 that localizes to specific tissues for diagnostic visualization. The mechanism involves incorporation into selenoproteins, enabling detection of organ function and pathology.
LOE Approaching
This legacy diagnostic agent faces imminent loss of exclusivity with minimal current market activity, suggesting limited team expansion and focus on managed decline.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
Working on SELENOMETHIONINE SE 75 offers limited career growth given zero linked job openings and approaching LOE status. This role suits professionals in legacy product stewardship, regulatory maintenance, or transition planning rather than career advancement.
Product ManagerRegulatory Affairs Specialist
Worked on SELENOMETHIONINE SE 75 at GE HealthCare? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.